ALX Oncology(ALXO) - 2025 Q4 - Earnings Call Transcript

ALX Oncology (NasdaqGS:ALXO) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsBarbara Klencke - Chief Medical OfficerHarish Shantharam - CFOJason Lettmann - CEORamakanth Swayampakula - Managing DirectorConference Call ParticipantsAllison Bratzel - Senior Research AnalystDaniel Braun - AnalystRoger Song - Senior Equity Research AnalystSam Slutsky - Senior Research AnalystOperatorGreetings, and welcome to the ALX Oncology Q4 2025 financial results call and webcast. At this time, all par ...